rVSV-Nipah
Pre-clinical- Indications
- Nipah virus infection
Company intelligence / Profile preview
Crozet BioPharma
Devens, Massachusetts, United Statescrozetbiopharma.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company has a multidisciplinary team with experience in successful product launches in infectious disease space and contributed to the first successful Ebola vaccine licensure efforts. They provide external development teams to accelerate pipeline progress for clients.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccinesBiological products for infectious diseases and cancer
- Industry
- Contract Research Organization
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Crozet BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crozet BioPharma.